Ignite Creation Date:
2025-12-24 @ 6:41 PM
Ignite Modification Date:
2026-04-04 @ 1:37 PM
Study NCT ID:
NCT00000857
Status:
COMPLETED
Last Update Posted:
2021-10-29
First Post:
1999-11-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cells/mm3 or 300-500 Cells/mm3
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | HIV Infections | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Recombinant Proteins | View |
| None | T-Lymphocytes | View |
| None | Dose-Response Relationship, Drug | View |
| None | Mycobacterium avium Complex | View |
| None | CD4 Lymphocyte Count | View |
| None | Interleukin-12 | View |
| None | Killer Cells, Natural | View |
| None | Th1 Cells | View |
| None | Interferon Type II | View |